HPRA Drug Safety Newsletter Edition 88

Download: hpra-drug-safety-newsletter-edition-88.pdf 245 KB

 The latest edition of the HPRA Drug Safety Newsletter (DSN) includes important updates to support the safe and appropriate use of the following medicines:

Granulocyte Colony Stimulating Factors (G-CSFs) - Risk of aortitis

Ocaliva (obeticholic acid) - Risk of serious liver injury in patients with pre-existing moderate or severe hepatic impairment. Reminder of differential dosing recommendations

Clarithromycin - Reminder on cardiovascular safety and risk minimisation advice

Adverse Reactions Reporting - Reminder

« Back